# TOFACITINIB
> **ANDA217299** · Abbreviated New Drug Application (Generic) · Sponsor: MSN PHARMS INC · Approved 2023-01-06
## Drug
- **FDA Application Number:** ANDA217299
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOFACITINIB
- **Generic name:** Tofacitinib Citrate
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MSN PHARMS INC
- **First approval:** 2023-01-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217299)
---
*AI Analytics · CC0 1.0*